News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
630,235 Results
Type
Article (38275)
Company Profile (124)
Press Release (591825)
Multimedia
Podcasts (113)
Webinars (15)
Section
Business (185147)
Career Advice (1876)
Deals (31452)
Drug Delivery (108)
Drug Development (70590)
Employer Resources (140)
FDA (15523)
Job Trends (13285)
News (310991)
Policy (30215)
Tag
Academia (2154)
Academic (2)
Accelerated approval (11)
Adcomms (19)
Allergies (111)
Alliances (48714)
ALS (115)
Alzheimer's disease (1319)
Antibody-drug conjugate (ADC) (156)
Approvals (15625)
Artificial intelligence (351)
Autoimmune disease (46)
Automation (25)
Bankruptcy (279)
Best Places to Work (10382)
BIOSECURE Act (17)
Biosimilars (141)
Biotechnology (81)
Bladder cancer (101)
Brain cancer (34)
Breast cancer (372)
Cancer (3031)
Cardiovascular disease (257)
Career advice (1608)
Career pathing (26)
CAR-T (196)
CDC (30)
Cell therapy (558)
Cervical cancer (30)
Clinical research (58855)
Collaboration (1187)
Company closure (2)
Compensation (483)
Complete response letters (37)
COVID-19 (2351)
CRISPR (67)
C-suite (435)
Cystic fibrosis (106)
Data (3583)
Decentralized trials (2)
Denatured (35)
Depression (76)
Diabetes (384)
Diagnostics (6238)
Digital health (26)
Diversity (5)
Diversity, equity & inclusion (34)
Drug discovery (166)
Drug pricing (123)
Drug shortages (31)
Duchenne muscular dystrophy (164)
Earnings (79409)
Editorial (43)
Employer branding (17)
Employer resources (120)
Events (94796)
Executive appointments (803)
FDA (17644)
Fibrodysplasia Ossificans Progressiva (3)
Friedreich's ataxia (2)
Frontotemporal dementia (11)
Funding (940)
Gene editing (133)
Generative AI (32)
Gene therapy (432)
GLP-1 (785)
Government (4121)
Grass and pollen (7)
Guidances (327)
Healthcare (15808)
HIV (39)
Huntington's disease (28)
IgA nephropathy (47)
Immunology and inflammation (157)
Immuno-oncology (12)
Indications (47)
Infectious disease (2530)
Inflammatory bowel disease (142)
Inflation Reduction Act (13)
Influenza (81)
Intellectual property (163)
Interviews (319)
IPO (14153)
IRA (43)
Job creations (3299)
Job search strategy (1357)
Kidney cancer (10)
Labor market (45)
Layoffs (435)
Leadership (24)
Legal (7005)
Liver cancer (72)
Longevity (9)
Lung cancer (441)
Lymphoma (222)
Machine learning (21)
Management (54)
Manufacturing (568)
MASH (101)
Medical device (12643)
Medtech (12662)
Mergers & acquisitions (18092)
Metabolic disorders (898)
Multiple sclerosis (105)
NASH (13)
Neurodegenerative disease (146)
Neuropsychiatric disorders (33)
Neuroscience (2074)
NextGen: Class of 2025 (5449)
Non-profit (3492)
Now hiring (31)
Obesity (417)
Opinion (241)
Ovarian cancer (87)
Pain (124)
Pancreatic cancer (138)
Parkinson's disease (184)
Partnered (18)
Patents (359)
Patient recruitment (223)
Peanut (49)
People (50421)
Pharmaceutical (38)
Pharmacy benefit managers (18)
Phase I (18030)
Phase II (25571)
Phase III (19947)
Pipeline (2414)
Policy (210)
Postmarket research (2311)
Preclinical (7745)
Press Release (71)
Prostate cancer (164)
Psychedelics (31)
Radiopharmaceuticals (237)
Rare diseases (496)
Real estate (5554)
Recruiting (52)
Regulatory (22041)
Reports (36)
Research institute (2014)
Resumes & cover letters (276)
Rett syndrome (12)
RNA editing (12)
RSV (51)
Schizophrenia (105)
Series A (159)
Series B (109)
Service/supplier (9)
Sickle cell disease (63)
Special edition (16)
Spinal muscular atrophy (137)
Sponsored (32)
Startups (3094)
State (1)
Stomach cancer (11)
Supply chain (91)
Tariffs (76)
The Weekly (77)
Vaccines (767)
Venture capital (42)
Weight loss (277)
Women's health (44)
Worklife (16)
Date
Last 7 days (469)
Last 30 days (1772)
Last 365 days (27125)
2025 (20274)
2024 (31180)
2023 (35755)
2022 (46455)
2021 (50504)
2020 (49107)
2019 (41467)
2018 (31251)
2017 (30516)
2016 (29548)
2015 (34450)
2014 (27414)
2013 (23610)
2012 (25058)
2011 (25414)
2010 (23272)
Location
Africa (743)
Alabama (65)
Alaska (6)
Arizona (188)
Arkansas (13)
Asia (38947)
Australia (6362)
California (7372)
Canada (2413)
China (775)
Colorado (337)
Connecticut (336)
Delaware (216)
Europe (84554)
Florida (1169)
Georgia (274)
Hawaii (2)
Idaho (50)
Illinois (646)
India (37)
Indiana (404)
Iowa (12)
Japan (278)
Kansas (104)
Kentucky (19)
Louisiana (13)
Maine (72)
Maryland (1069)
Massachusetts (5438)
Michigan (272)
Minnesota (398)
Mississippi (2)
Missouri (102)
Montana (28)
Nebraska (16)
Nevada (96)
New Hampshire (64)
New Jersey (2319)
New Mexico (27)
New York (2098)
North Carolina (1099)
North Dakota (9)
Northern California (3363)
Ohio (234)
Oklahoma (16)
Oregon (32)
Pennsylvania (1596)
Puerto Rico (16)
Rhode Island (37)
South America (1110)
South Carolina (45)
South Dakota (1)
Southern California (2869)
Tennessee (126)
Texas (1176)
United States (27882)
Utah (226)
Virginia (209)
Washington D.C. (61)
Washington State (624)
West Virginia (4)
Wisconsin (71)
Wyoming (1)
630,235 Results for "spectrum chemicals and laboratory products".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Cytek Biosciences Brings Full Spectrum Cell Analysis to Leading Clinical Global Conferences ICCS and ESCCA
September 10, 2025
·
8 min read
Opinion
Fate of FDA’s Laboratory-Developed Testing Final Rule Hints at
Chevron
Overturn’s Ramifications
In one of the first demonstrations of the impact of last year’s Loper Supreme Court decision on challenges to agency authority, a judge ruled that the FDA does not have authority to regulate tests developed by clinical laboratories.
September 29, 2025
·
4 min read
·
Megan Robertson
Press Releases
Health Canada Approves Slenyto® - Extended-Release Melatonin Formulation - as a Prescription Drug for Insomnia in Children with Autism Spectrum disorder and Smith Magenis Syndrome
September 11, 2025
·
4 min read
Press Releases
Servier acquires potential treatment for Fragile X syndrome, the most common genetic cause of autism spectrum disorder
September 8, 2025
·
6 min read
Press Releases
Bioxytran’s Breakthrough Broad-Spectrum Antiviral Technology Poised to Revolutionize Respiratory Infection Treatment
August 8, 2025
·
3 min read
Press Releases
Osivax Announces First Participant Vaccinated in Phase 2b Trial Evaluating Broad-Spectrum Influenza A Vaccine Candidate, OVX836
September 16, 2025
·
3 min read
Press Releases
Cocrystal Pharma Receives FDA IND Clearance for Challenge Study of Oral Broad-Spectrum Protease Inhibitor CDI-988, a Potential First Antiviral for Norovirus Prevention and Treatment
September 9, 2025
·
4 min read
Press Releases
Measles Cases Increasing Worldwide, Need the New NV-387 Broad-Spectrum Antiviral to Combat, Says NanoViricides
July 31, 2025
·
10 min read
Press Releases
Measles Now Has a Drug - NV-387 Broad-Spectrum Antiviral Successful in Animal Studies, says NanoViricides
July 21, 2025
·
7 min read
Press Releases
Model Medicines Selected to Present Preclinical Proof-of-Concept Data for Broad-Spectrum Antiviral MDL-001 at IDWeek 2025
August 21, 2025
·
1 min read
1 of 63,024
Next
